drugset / Trial / NCT07014917
Intermittent Versus Continuous Venetoclax With Acalabrutinib for CLL/SLL
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized Phase II study of intermittent versus continuous venetoclax therapy with Acalabrutinib in previously untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Timeline
- Start
- 2025-12-05
- Primary completion
- 2028-06-05
- Completion
- 2032-06-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Venetoclax | Small molecule | — | — |
| Background | Acalabrutinib | Small molecule | — | — |